{"meta":{"query_hash":"be831015451b","filters":{"venue":"Journal of Hepatocellular Carcinoma"},"cohort_total":9,"direct_labels_cover":0,"predictions_cover":9,"exported":9,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/be831015451b","api":"https://metacan.xera.ac/api/v1/cohort?venue=Journal+of+Hepatocellular+Carcinoma"},"results":[{"id":"W2588272840","doi":"10.2147/jhc.s125396","title":"Liver Imaging Reporting and Data System: an expert consensus statement","year":2017,"lang":"en","type":"editorial","venue":"Journal of Hepatocellular Carcinoma","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; University of Ottawa","funders":"National Cancer Institute","keywords":"Hepatocellular carcinoma; Cirrhosis; Medicine; Incidence (geometry); Medical physics; Statement (logic); Radiology; Computer science; Internal medicine; Political science","score_opus":0.12039973283420577,"score_gpt":0.3336991209150809,"score_spread":0.21329938808087515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588272840","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002820453,0.026879448,0.0040752827,0.35897827,0.60287166,0.0004940534,0.0006816244,0.0002622901,0.005475303],"genre_scores_gemma":[0.0033150073,0.044892073,0.011254908,0.19738013,0.7282158,0.00082305993,0.002070033,0.0003295225,0.011719486],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9595203,0.0099631585,0.01423513,0.0016022808,0.01356796,0.0011111584],"domain_scores_gemma":[0.8240707,0.038163662,0.0124235535,0.004181876,0.11287226,0.0082880305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04988596,0.0017366384,0.003262397,0.004870028,0.0021958202,0.0064018336,0.0052254125,0.014044711,0.004796947],"category_scores_gemma":[0.10930442,0.0012251,0.0037573786,0.00302921,0.0025344542,0.0054865084,0.0027231458,0.025518756,0.0089984005],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028698874,0.000020232428,0.000096944736,0.00069849094,0.00003447762,0.0001510983,0.000055970497,0.000077397526,0.00012302365,0.0006110486,0.9664531,0.03164956],"study_design_scores_gemma":[0.00006708438,0.000025779165,0.0004906412,0.004491186,0.00010189111,0.0005885583,0.00009182002,0.00025958335,0.0002343785,0.0017077039,0.9918933,0.00004811605],"about_ca_topic_score_codex":0.0026176265,"about_ca_topic_score_gemma":0.0029652328,"teacher_disagreement_score":0.04988596,"about_ca_system_score_codex":0.0038700528,"about_ca_system_score_gemma":0.015132541,"threshold_uncertainty_score":0.2638253},"labels":[],"label_agreement":null},{"id":"W2911517786","doi":"10.2147/jhc.s186239","title":"<p>LI-RADS: a conceptual and historical review from its beginning to its recent integration into AASLD clinical practice guidance</p>","year":2019,"lang":"en","type":"review","venue":"Journal of Hepatocellular Carcinoma","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":149,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Health Sciences Centre; Sunnybrook Health Science Centre; Western University; University of Calgary; Centre Hospitalier de l’Université de Montréal; University of Toronto","funders":"National Cancer Institute","keywords":"Medicine; Hepatocellular carcinoma; Terminology; Cirrhosis; Clinical Practice; Contrast-enhanced ultrasound; Radiology; Ultrasound; Medical physics; Internal medicine; Family medicine","score_opus":0.21311997714158254,"score_gpt":0.36601702481176296,"score_spread":0.15289704767018042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911517786","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000084697,0.99646074,0.0003778583,0.0011968479,0.00043356116,0.00001888336,0.00008225054,0.000017170816,0.0013280346],"genre_scores_gemma":[0.00060080655,0.99685943,0.00093157456,0.00065933,0.00032507814,0.00002992004,0.00012010264,0.0000072806097,0.00046638312],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990995,0.00023029732,0.00021886214,0.0001297393,0.00026406234,0.000057490768],"domain_scores_gemma":[0.99621457,0.00212657,0.00045914488,0.00010192186,0.0009753125,0.00012242864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003359347,0.0009088597,0.0013079074,0.0071597034,0.00039988823,0.002010256,0.0012887911,0.001272981,0.0038287516],"category_scores_gemma":[0.006328898,0.00050088007,0.0012043151,0.008547118,0.0010698263,0.0027816445,0.0010583557,0.002340923,0.0028906846],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006833273,0.000037460497,0.0004073512,0.029423082,0.000122058256,0.00010598781,0.0001584296,0.00035922727,0.00042786516,0.0073158657,0.072469674,0.88910466],"study_design_scores_gemma":[0.000008785453,0.000046445453,0.0007941736,0.012067956,0.00015328864,0.0006123277,0.00006477367,0.00007856645,0.00018434448,0.0016903055,0.98427397,0.000025105552],"about_ca_topic_score_codex":0.002983751,"about_ca_topic_score_gemma":0.004374849,"teacher_disagreement_score":0.0071597034,"about_ca_system_score_codex":0.0018996149,"about_ca_system_score_gemma":0.005394301,"threshold_uncertainty_score":0.017766118},"labels":[],"label_agreement":null},{"id":"W3169181984","doi":"10.2147/jhc.s284403","title":"Current Understanding of Ablative Radiation Therapy in Hepatocellular Carcinoma","year":2021,"lang":"en","type":"review","venue":"Journal of Hepatocellular Carcinoma","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Ablative case; Medicine; Hepatocellular carcinoma; Radiofrequency ablation; Radiation therapy; Radiology; Ablation; Oncology; Internal medicine","score_opus":0.18518813754771246,"score_gpt":0.327991669934234,"score_spread":0.14280353238652155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3169181984","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003892568,0.99951184,0.000032805885,0.00010622682,0.00004014902,0.000002605054,0.000011314274,0.0000022862494,0.00025379102],"genre_scores_gemma":[0.0002336621,0.99955934,0.000050350893,0.000058535985,0.000031394506,0.0000032027676,0.000010102267,3.7580932e-7,0.00005307768],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997117,0.000057710182,0.00007468773,0.00004542581,0.00009146185,0.000019006276],"domain_scores_gemma":[0.9993024,0.00045416632,0.00011046835,0.000015567077,0.00009762222,0.000019886302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008186861,0.0008631073,0.0018903402,0.0028684076,0.00023632906,0.0010143607,0.00092494895,0.00096474105,0.0033317204],"category_scores_gemma":[0.0013058784,0.00031910196,0.0011761279,0.0037781799,0.00044535787,0.0013538516,0.000592597,0.0011296388,0.00093758747],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000074922646,0.00004379892,0.00020293344,0.11755144,0.00029346524,0.00015535232,0.000093471645,0.00042313922,0.0006454066,0.0018862273,0.01321954,0.86541027],"study_design_scores_gemma":[0.00004672519,0.00019881864,0.0031538876,0.07114507,0.0014156793,0.0022586058,0.00015256317,0.00017974584,0.00044029148,0.0035948125,0.917373,0.000040753384],"about_ca_topic_score_codex":0.0023820954,"about_ca_topic_score_gemma":0.0031082607,"teacher_disagreement_score":0.0033317204,"about_ca_system_score_codex":0.00081017,"about_ca_system_score_gemma":0.0017262995,"threshold_uncertainty_score":0.011145711},"labels":[],"label_agreement":null},{"id":"W4306664823","doi":"10.2147/jhc.s372571","title":"Incidence of Hepatocellular Carcinoma and Decompensated Liver Cirrhosis and Prognostic Accuracy of the PAGE-B HCC Risk Score in a Low Endemic Hepatitis B Virus Infected Population","year":2022,"lang":"en","type":"article","venue":"Journal of Hepatocellular Carcinoma","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Global Health Research","funders":"Scandinavian Society for Antimicrobial Chemotherapy Foundation","keywords":"Hepatocellular carcinoma; Medicine; Cirrhosis; Incidence (geometry); Internal medicine; Hepatitis B virus; Gastroenterology; Population; Hepatitis a virus; Virology; Virus; Oncology; Environmental health","score_opus":0.02194930111353136,"score_gpt":0.24003164087028353,"score_spread":0.21808233975675217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306664823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995338,0.00015998035,0.00003407072,0.0000065483623,0.0000016780384,0.0000019592512,0.00013519639,0.0000011523083,0.00012562846],"genre_scores_gemma":[0.99968266,0.000048815746,0.00002787691,0.0000021541289,0.0000013999496,0.0000011841998,0.00019138875,3.9706146e-7,0.000044051703],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996001,0.000110400564,0.00005813907,0.00010967009,0.00006995456,0.0000517142],"domain_scores_gemma":[0.99899846,0.0001530726,0.0005238472,0.00007649891,0.000091413414,0.0001565873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061588816,0.00019240536,0.00034181782,0.000804453,0.0002473411,0.000598826,0.00025713854,0.00029866863,0.0006628427],"category_scores_gemma":[0.0016885414,0.00030016043,0.0003831588,0.0005571375,0.0002529648,0.0003034119,0.0005678201,0.00029554486,0.00015173483],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000789041,0.0000072055814,0.9993801,0.0000048617967,0.00002580349,0.000016952272,0.00001976642,0.00003933579,0.00007990076,0.0000059343442,0.000014613257,0.0003264246],"study_design_scores_gemma":[0.0000044159747,0.000039861447,0.99950075,0.000003579335,0.00001910391,0.00009563832,0.000055248114,0.00019925366,0.000028742026,0.000009576742,0.000041722757,0.00000201386],"about_ca_topic_score_codex":0.0073798513,"about_ca_topic_score_gemma":0.0058975425,"teacher_disagreement_score":0.0073798513,"about_ca_system_score_codex":0.00027668974,"about_ca_system_score_gemma":0.00025398633,"threshold_uncertainty_score":0.014673829},"labels":[],"label_agreement":null},{"id":"W4393992603","doi":"10.2147/jhc.s447848","title":"Macroscopic Characterization of Hepatocellular Carcinoma: An Underexploited Source of Prognostic Factors","year":2024,"lang":"en","type":"article","venue":"Journal of Hepatocellular Carcinoma","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Mount Sinai Health System","keywords":"Hepatocellular carcinoma; Medicine; Liver cancer; Carcinoma; Internal medicine; Oncology; Pathology","score_opus":0.050291984591866824,"score_gpt":0.25522587327055196,"score_spread":0.20493388867868514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393992603","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009403102,0.986927,0.0013701898,0.00089542515,0.00011407636,0.00001639214,0.00031308402,0.000009922812,0.0009509062],"genre_scores_gemma":[0.19229852,0.8024491,0.0024650067,0.0008622146,0.0007250038,0.00004531312,0.00083533325,0.000022771314,0.00029674664],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99482626,0.0019658098,0.0013147086,0.0006451101,0.0011233925,0.00012463049],"domain_scores_gemma":[0.96153474,0.02975516,0.0052410765,0.0012597189,0.0020513723,0.0001579149],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008917121,0.0005157104,0.0023601423,0.0031249197,0.00027802645,0.0025924498,0.0006089334,0.00048461667,0.0013399465],"category_scores_gemma":[0.019512592,0.00027367103,0.0014123875,0.004463845,0.0012789774,0.0020283184,0.0008398492,0.0007602959,0.00023091894],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007856193,0.00004379455,0.10032932,0.08694822,0.006009128,0.00044769276,0.0008557246,0.00090872194,0.0018635987,0.0041347085,0.0033485629,0.79432493],"study_design_scores_gemma":[0.0001513329,0.0012323846,0.5179719,0.10746214,0.032660376,0.010463011,0.0037884822,0.0014714041,0.0047473614,0.018098403,0.3016183,0.00033488026],"about_ca_topic_score_codex":0.0016624081,"about_ca_topic_score_gemma":0.0027258717,"teacher_disagreement_score":0.008917121,"about_ca_system_score_codex":0.00061159616,"about_ca_system_score_gemma":0.0015819526,"threshold_uncertainty_score":0.047158837},"labels":[],"label_agreement":null},{"id":"W4406931481","doi":"10.2147/jhc.s490226","title":"TRACE Model: Predicting Treatment Response to Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma","year":2025,"lang":"en","type":"article","venue":"Journal of Hepatocellular Carcinoma","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Artificial Intelligence in Medicine (Canada)","funders":"National Natural Science Foundation of China","keywords":"Hepatocellular carcinoma; TRACE (psycholinguistics); Medicine; Response Evaluation Criteria in Solid Tumors; Internal medicine; Oncology; Chemotherapy; Progressive disease","score_opus":0.038630358954733025,"score_gpt":0.26603551546983484,"score_spread":0.22740515651510182,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406931481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9462566,0.0016129393,0.04452689,0.0012041193,0.0001261108,0.0001915843,0.0035439061,0.0011015715,0.0014363193],"genre_scores_gemma":[0.98843735,0.00020400152,0.007033986,0.00013081048,0.00007079263,0.00012328252,0.0032856048,0.00003145982,0.00068260176],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.999271,0.0003531722,0.0000481838,0.00015217267,0.000106887484,0.000068758636],"domain_scores_gemma":[0.9983542,0.0009326312,0.00027887366,0.000091047965,0.00020000937,0.00014329566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029122627,0.0011834066,0.001130073,0.0017959558,0.00025865837,0.0009611913,0.00096669764,0.0006086836,0.001153058],"category_scores_gemma":[0.0048728758,0.00024108266,0.0012734751,0.0006475988,0.00023561426,0.00043300344,0.00075502525,0.00093942723,0.0003177059],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043169023,0.0011681987,0.50481546,0.00023042817,0.0017077073,0.00030010138,0.000095248164,0.32202145,0.0019844675,0.0005642323,0.008361911,0.15443392],"study_design_scores_gemma":[0.00010868019,0.00075893255,0.027583266,0.000026206291,0.00025086585,0.0001368976,0.000028219365,0.9691556,0.00049870746,0.00070821634,0.0007203481,0.000024001458],"about_ca_topic_score_codex":0.007422268,"about_ca_topic_score_gemma":0.0056299316,"teacher_disagreement_score":0.007422268,"about_ca_system_score_codex":0.0008078915,"about_ca_system_score_gemma":0.001153286,"threshold_uncertainty_score":0.015401721},"labels":[],"label_agreement":null},{"id":"W4409143672","doi":"10.2147/jhc.s462701","title":"ALBI Grade Enables Risk Stratification for Bleeding Events and Refines Prognostic Prediction in Advanced HCC Following Atezolizumab and Bevacizumab","year":2025,"lang":"en","type":"article","venue":"Journal of Hepatocellular Carcinoma","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Toronto General Hospital","funders":"","keywords":"Atezolizumab; Bevacizumab; Risk stratification; Medicine; Internal medicine; Oncology; Cancer; Chemotherapy; Nivolumab; Immunotherapy","score_opus":0.030029652232881336,"score_gpt":0.26245994357902064,"score_spread":0.2324302913461393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409143672","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980697,0.0004780736,0.00055005134,0.00006887727,0.000013932664,0.000011782196,0.00014236262,0.000012841825,0.00065237225],"genre_scores_gemma":[0.9993808,0.00007147048,0.00028431584,0.000011523019,0.000017066923,0.0000035978985,0.00015305965,0.0000025302575,0.00007561036],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99948525,0.00018197697,0.00007062398,0.00007420009,0.00010415415,0.00008369492],"domain_scores_gemma":[0.99744487,0.00054198847,0.0011913243,0.00013840992,0.00031365835,0.00036972194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013065502,0.0003677203,0.0003479643,0.0014109348,0.00020266823,0.0007161484,0.0002447986,0.0002933997,0.0008661948],"category_scores_gemma":[0.0043037175,0.00012550913,0.00043289136,0.00088293815,0.00027669923,0.00036811014,0.0003970821,0.00042128804,0.00022241338],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003421891,0.000011324362,0.99545324,0.000004859515,0.000022611011,0.000046938985,0.00001060689,0.00010828513,0.00024657443,0.000012544805,0.000068554946,0.003672262],"study_design_scores_gemma":[0.0000134473385,0.00019011584,0.9965089,0.000007674341,0.00005835879,0.00048278883,0.00003427649,0.0019210791,0.0004159202,0.00008977713,0.00027235303,0.000005178644],"about_ca_topic_score_codex":0.0015890782,"about_ca_topic_score_gemma":0.0021882432,"teacher_disagreement_score":0.0015890782,"about_ca_system_score_codex":0.0003717581,"about_ca_system_score_gemma":0.0002559774,"threshold_uncertainty_score":0.0069097877},"labels":[],"label_agreement":null},{"id":"W4409586510","doi":"10.2147/jhc.s510460","title":"A Novel Prognostic Signature Integrating Immune and Glycolytic Pathways for Enhanced Prognosis and Immunotherapy Prediction in Hepatocellular Carcinoma","year":2025,"lang":"en","type":"article","venue":"Journal of Hepatocellular Carcinoma","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Hepatocellular carcinoma; Immunotherapy; Signature (topology); Immune system; Medicine; Glycolysis; Oncology; Cancer research; Internal medicine; Immunology; Metabolism","score_opus":0.01717868099964072,"score_gpt":0.24025928278405792,"score_spread":0.2230806017844172,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409586510","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909933,0.00094463385,0.005506045,0.00015379014,0.000020142697,0.000037975227,0.0014980605,0.00009161473,0.0007542821],"genre_scores_gemma":[0.99580765,0.0001753697,0.0026103721,0.00003107604,0.000016488879,0.000025218424,0.0011622311,0.000007741829,0.00016386522],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998173,0.00004128728,0.000016692438,0.00004278455,0.000043781365,0.000038192033],"domain_scores_gemma":[0.9995425,0.00010198983,0.00017756037,0.000031666405,0.000087859706,0.000058497717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006556235,0.00041052047,0.00041458674,0.0011960246,0.0001929832,0.0005526746,0.00019714724,0.00023419499,0.00077258714],"category_scores_gemma":[0.000948554,0.00009019056,0.00041204388,0.0010793693,0.00022743552,0.00027275595,0.00041380082,0.00031852597,0.00020075784],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008605488,0.00009798142,0.9182586,0.00015841861,0.00021227964,0.00020401656,0.000065552034,0.005609477,0.02320195,0.00025013374,0.0009040481,0.05017709],"study_design_scores_gemma":[0.000049344602,0.00060177693,0.91295636,0.000065247026,0.00057296525,0.0009363536,0.00023954117,0.06523135,0.01459462,0.0017605849,0.0029437412,0.00004819859],"about_ca_topic_score_codex":0.00064717,"about_ca_topic_score_gemma":0.0012438459,"teacher_disagreement_score":0.0011960246,"about_ca_system_score_codex":0.0003310346,"about_ca_system_score_gemma":0.00045592873,"threshold_uncertainty_score":0.0034673214},"labels":[],"label_agreement":null},{"id":"W4413324164","doi":"10.2147/jhc.s526170","title":"A Patient Charter to Improve Care for Hepatocellular Carcinoma","year":2025,"lang":"en","type":"article","venue":"Journal of Hepatocellular Carcinoma","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Bayer HealthCare; AstraZeneca","keywords":"Hepatocellular carcinoma; Charter; Medicine; Oncology; Internal medicine; Political science","score_opus":0.024922006563443354,"score_gpt":0.2479311520852572,"score_spread":0.22300914552181386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413324164","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.041548867,0.0060673486,0.16090845,0.66469175,0.021183783,0.006413747,0.0017630019,0.004633879,0.09278915],"genre_scores_gemma":[0.32396674,0.0073885634,0.53169715,0.081693135,0.00855387,0.005498676,0.0031740998,0.0008101426,0.037217725],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.968234,0.021512542,0.0024407178,0.0007884281,0.005774907,0.0012494025],"domain_scores_gemma":[0.9090115,0.02493042,0.013478501,0.007869082,0.028955907,0.015754614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.05130004,0.0006208772,0.0005596869,0.0016593293,0.0045756144,0.004014846,0.0019314721,0.0028467053,0.010095255],"category_scores_gemma":[0.09325992,0.00035975533,0.0008221963,0.0012724131,0.002119146,0.0057329857,0.005533732,0.007384641,0.0023162344],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002142799,0.0005295705,0.0138659,0.0006121736,0.000042298867,0.00077026343,0.009349735,0.002068569,0.0012409923,0.036245257,0.6067685,0.3282925],"study_design_scores_gemma":[0.00025269264,0.0007913076,0.012511716,0.0019161602,0.000048329213,0.0013903558,0.0072529023,0.0037169245,0.0019486421,0.017952733,0.9519507,0.0002675689],"about_ca_topic_score_codex":0.003887367,"about_ca_topic_score_gemma":0.009563134,"teacher_disagreement_score":0.05130004,"about_ca_system_score_codex":0.005174683,"about_ca_system_score_gemma":0.031781256,"threshold_uncertainty_score":0.27130377},"labels":[],"label_agreement":null}]}